DESARROLLO DE METODOS DIAGNOSTICOS Y DE DETECCION SELECTIVA PARA LA DIABETES TIPO 2





DESARROLLO DE METODOS DIAGNOSTICOS Y DE DETECCION SELECTIVA PARA LA DIABETES TIPO 2

(especial para SIIC © Derechos reservados)
La medición pareada de las concentraciones de glucosa plasmática en ayunas y hemoglobina glucosilada es un método sencillo para identificar a las personas con alto riesgo de desarrollo de diabetes.
Autor:
Gary T.c. Ko
Columnista Experto de SIIC
Artículos publicados por Gary T.c. Ko
Recepción del artículo
12 de Agosto, 2002
Primera edición
12 de Septiembre, 2002
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
La posibilidad de desarrollo de complicaciones de la diabetes en individuos con hiperglucemia es continua. Es importante identificar tempranamente a las personas con riesgo de hiperglucemia y reducir al mínimo la posibilidad de producir una falsa alarma. La prueba de tolerancia oral a la glucosa o el nivel de glucemia a las 2 horas es el método diagnóstico de elección; no obstante, la incomodidad que representa para los pacientes, la dificultad en su realización y la escasa reproducibilidad de los resultados limitan su empleo. Se ha mostrado que la combinación del nivel plasmático de glucosa en ayunas y la determinación de hemoglobina glucosilada como prueba de detección selectiva o diagnóstica para la diabetes tiene más valor predictivo que cualquiera de esos parámetros determinado aisladamente. En nuestra experiencia los valores pareados de glucemia en ayunas y de hemoglobina glucosilada han resultado muy útiles para identificar personas con riesgo de diabetes. En los que se detectan valores pareados mayores que un límite determinado está indicada la prueba de tolerancia oral a la glucosa. Más del 60% de los habitantes de origen chino de Hong Kong pueden ser diabéticos de acuerdo con la determinación de glucemia a las 2 horas. Aun cuando el nivel plasmático de glucosa no sea diagnóstico en esa ocasión, esas personas deben ser controladas atentamente porque su riesgo de desarrollar diabetes franca es muy elevado. Creemos que la determinación pareada de los niveles de glucemia en ayunas y la concentración de hemoglobina glucosilada es un método práctico y económicamente efectivo, que mejora la especificidad y sensibilidad de la pesquisa de individuos diabéticos.

Palabras clave
Glucemia en ayunas, hemoglobina glucosilada, pesquisa


Artículo completo

(castellano)
Extensión:  +/-8.95 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
The risk of developing diabetic complications in subjects with hyperglycemia is a continuum. It is important to detect early those subjects at risk of hyperglycemia while minimizing the possibility of giving a false alarm. Oral glucose tolerance test or 2-hour plasma glucose level is the gold standard, however, its use is limited by its inconvenience to patients, laborious, and poor reproducibility. Combining fasting plasma glucose and glycated hemoglobin as screening or diagnostic test for diabetes has been shown to be more predictive than either parameter alone. We found that the paired values of a fasting plasma glucose and glycated hemoglobin very useful to identify potential diabetic subjects. Those with the paired values higher than certain cutoff should proceed to an oral glucose tolerance test. In Hong Kong Chinese, more than 60% of them may be diabetic based on the 2-hour plasma glucose. Even if their 2-hour plasma glucose is not diagnostic at that time, they should be closely followed up since their risk of progressing to diabetes is very high. We believe using a paired value of fasting plasma glucose and glycated hemoglobin is practical, cost-effective and optimizing both sensitivity and specificity in screening diabetic subjects.

Key words
Fasting plasma glucose, glycated hemoglobin, screening


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Endocrinología y Metabolismo
Relacionadas: Diagnóstico por Laboratorio, Medicina Interna, Nutrición



Comprar este artículo
Extensión: 8.95 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo
  1. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series 727, World Health Organization. Geneva 1985.
  2. Jarrett RJ, Keen H. Hyperglycemia and diabetes mellitus. Lancet 1976;2:1009-12.
  3. Sayegh HA, Jarrett RJ. Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey. Lancet 1979;2:431-3.
  4. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus. Diabet Med 1993;10:305-12.
  5. Nijpels G. Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998;28(Suppl 2):8-13.
  6. Sayetta RB, Murphy RS. Summary of current diabetes-related data from the National Center for Health Statistics. Diabetes Care 1979;2:105-19.
  7. Taylor R, Zimmet P. Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus. Diabetes Care 1981;4:556-8.
  8. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-34.
  9. Ramachandran A, Snehalatha C, Vijay V, Viswanathan M. Fasting plasma glucose in the diagnosis of diabetes mellitus: a study from southern India. Diabet Med 1993;10:811-3.
  10. Bortheiry AL, Malerbi DA, Franco LJ. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT. Diabetes Care 1994;17:1269-72.
  11. Larsson H, Ahren B, Lindgarde F, Berglund G. Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women. J Intern Med 1995;237:537-41.
  12. Cockram CS, Lau JT, Chan AY, Woo J, Swaminathan R. Assessment of glucose tolerance test criteria for diagnosis of diabetes in Chinese subjects. Diabetes Care 1992;15:988-90.
  13. Ko GTC, Chan JCN, Lau E, Woo J, Cockram CS. Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese. Diabetes Care 1997;20:170-2.
  14. American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
  15. Alberti KGMM, Zimmet PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998;15:539-53.
  16. Perry RC, Shankar RR, Fineberg, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnositc levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001;24:465-71.
  17. Tanaka Y, Atsumi Y, Asahina T, Hosokawa K, Matsuoka K, Kinoshita J, Onuma T, Kawamori R. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care 1998;21:1133-7.
  18. American Diabetes Association. Screening for diabetes. Diabetes Care 2002;25(Suppl 1):S21-S24.
  19. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE: Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978;27:715-25.
  20. Ko GTC, Chan JCN, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 1998;35:62-7.
  21. DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes Reanalysis of European epidemiological data. Br Med J 1998;317:371-5.
  22. Ko GTC, Chan JCN, Woo J, Cockram CS. Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care 1998;21:2094-7.
  23. Wiener K, Roberts NB. The relative merits of hemoglobin A1c and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 1998;15:558-63.
  24. Bolli G, Compagnucci P, Cartechini MG, Santeusanio F, Cirotto C, Scionti L, Brunetti P. HbA1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose. Diabetes 1980;29:272-7.
  25. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997;20:1822-6.
  26. Little RR, England JD, Wiedmeyer HM, Madsen RW, Pettitt DJ, Knowler WC, Goldstein DE. Glycated hemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia 1994;37:252-6.
  27. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J 1994;308:1323-8.
  28. Little RR, England JD, Wiedmeyer HM, McKenzie EM, Pettitt DJ, Knowler WC, Goldstein DE. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening. Diabetes 1988;37:60-4.
  29. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 1996;276:1246-52.
  30. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 1999;281:1203-10.
  31. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A, Hisamichi S. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care 1991;14:1075-7.
  32. Hanson RL, Nelson RG, McCance DR, Beart JA, Charles MA, Pettitt DJ, Knowler WC. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 1993;153:2133-40.
  33. Bjornholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999;22:45-9.
  34. Hu YH, Pan XR, Liu PA, Li GW, Howard BV, Bennett PH. Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes Study. Acta Diabetol 1991;28:169-73.
  35. Chan JC, Cheung JC, Lau EM, Woo J, Chan AY, Swaminathan R, Cockrama CS. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care 1996;19:953-9.
  36. Modan M, Halkin H, Karasik A, Lusky A. Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 1984;119:431-44.
  37. Snehalatha C, Ramachandran A, Satyavani K, Vijay V. Limitations of glycosylated hemoglobin as an index of glucose intolerance. Diabetes Res Clin Pract 2000;47:129-33.
  38. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-15.
  39. Ko GTC, Chan JCN, Yeung VTF, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998;21:1221-5.
  40. Ko GTC, Chan JCN, Cockram CS. Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes. Diabetes Care 1998;21:2032-3.
  41. Ko GTC, Chan JCN, Cockram CS. The use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes in the community. Diabetes Care 1999;22:1908-9.
  42. Tajima N. The epidemiology of diabetes in Japan. In: Turtle JR, Kaneko T, Osato S, eds. Diabetes in the new millennium. Australia: The Pot Still Press, 1999: 23-30.
  43. Krebs JD, Robinson GM, Smith RB, Toomath RJ. Follow up testing of hyperglycemia during hospital admission: combined use of fasting plasma glucose and HbA1c. N Z Med J 2000;113:379-81.
  44. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000;23:1770-3.
  45. Ko GT, Cockram CS, Chan JC. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels J Med 2001;32:53-65.
  46. Ko GT. Diagnosing diabetes mellitus in the Asian population. Hong Kong Med J 2000;6:53-9.

Título español
Resumen
 Palabras clave
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

 English title
 Abstract
 Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618